Health Catalyst appoints Carle Health COO Matthew Kolb to board; Carle becomes shareholder

Health Catalyst, Inc.

Matthew Kolb, EVP & COO of Carle Health, appointed to board effective July 1, 2023, filling a newly created seat.
Carle Health purchased HCAT common stock on open market, becoming a meaningful shareholder.
Carle expanded client relationship in Dec 2022 with a five-year contract for tech-enabled managed services and all-access subscription.
Carle paid ~$5.5M in 2022; 2023 payments expected to slightly exceed 5% of HCAT's projected revenue.
Kolb will not receive director compensation beyond expense reimbursement.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Matthew Kolb

Director

HCAT · Health Catalyst, Inc.

Effective: 2023-07-01
Filed: February 28, 2023, 6:59 PM ET

On February 27, 2023, the board of directors (the “Board”) of Health Catalyst, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Matthew Kolb to the Board, effective July 1, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Matthew Kolb was appointed as Director at Health Catalyst, Inc..

Action: appointed
Role: Director

Exact text from the filing

On February 27, 2023, the board of directors (the “Board”) of Health Catalyst, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee, appointed Matthew Kolb to the Board, effective July 1, 2023.

View on SEC.gov

Health Catalyst, Inc. filing history →

Source: SEC EDGAR

accession 0001636422-23-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.